TickerFacts.

Inhibikase Therapeutics, Inc. (IKT): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-6, first reflected in a filing dated 2023-08-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

131.69M
As of 2025-12-31
132.03M
As of 2026-06-30
2020-12-31: 10.05M2021-12-31: 25.16M2022-12-31: 4.22M2023-12-31: 6.19M2024-12-31: 69.36M2025-12-31: 131.69M131.69M
2020-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-31131.69M+89.9%2026-03-26, Balance as of period end
2024-12-3169.36Mn/m2026-03-26, Balance as of period end
2023-12-316.19Mn/c2025-03-27, Balance as of period end
2022-12-314.22Mn/c2024-03-27, Balance as of period end
2021-12-3125.16M+150.3%2023-03-31, Balance as of period end
2020-12-3110.05Mn/a2022-03-31, Balance as of period end